'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera

TRENDING: Dancing Elephant Stomps 5 Of The Magnificent 7Â The battle between Pfizer (PFE) and Novo Nordisk (NVO) is "getting ugly," an analyst said Thursday as Metsera (MTSR) stock surged on reports that Pfizer has matched Novo's $10 billion bid. Pfizer is trying to salvage the $4.9 billion deal it announced in September to buy the small obesity-focused biotech company. Danish drugmaker Novo Nordisk came in with a strong $6.5 billion bid last week, then hiked it to $10 billion. Pfizer's last reported bid wa ...